Gonadal hormones Flashcards
what is the presentation of 17-alpha hydroxylase deficiency and tx for men and women?
- decreased sex hormones and cortisol, and increased in mineralocorticoids.
- pt presents c elevated BP and hypokalemia
- XY: decreased DHT may show cryptorchidism and indistinct genitalia.
- tx: androgens, glucocorticoids and anti-HTN
- XX: outwardly phenotypic female c normal internal sex organs but lack secondary sex characteristics
- -tx: estrogens, anti-HTN
what is the general mechanism of action of steroid hormones - estrogen, progesterone, testosterone?
- binds to the cytosolic receptor
- hormone-receptor complex (HRC) travels into nucleus
- activation of HRC leads to changes in the rates of transcription of steroid hormone regulated genes - modulate gene expression
what is the presentation of 21-alpha hydroxylase deficiency and tx?
- elevated sex hormones and decreased cortisol and mineralocorticoids.
- presents c decreased of BP, hyperkalemia, elevated renin activity and vol depletion
- over masculinization - pseudohermaphroditism in females
- tx: fluids + salt repletion; administer cortisol to decrease ACTH
what is the presentation of 11-beta hydroxylase deficiency and tx?
- elevated sex hormones and decreased cortisol, decreased mineralocorticoid (aldosterone) but increased increased 11-deoxycorticosterone.
- pt presents c elevated BP d/t elevated mineralcoticoid 11-deoxycorticosterone.
- over masculinization.
- tx: estrogens, anti-HTN
- what are sources of estrogen?
- what are the main estrogens?
- which one is more potent?
- ovary, adrenal gland, placenta, and in the blood from aromatization
- estradiol, estrone, and estriol
- estradiol
physiological effects of estrogens?
- sexual devel
- growth and devel of vagina, uterus, Fallopian tube and contribute to the breast enlargement.
- secondary sexual characteristics in females. - non-reproductive functions:
- reduce bone resorption; prevent the bone loss
- epiphyseal closure in long bones - pro-coagulation state
- increases factor II, VII, IX, X and XII
- decreases anti-thrombin III, protein C and S - favorable lipid profile
- increase HDL
- decrease LDL - effect on hormone levels
- increases the binding protein level of various hormones (cortisol, thyroxine, sex steroids)
- free hormone level is unaffected - increase cholesterol in bile- formation of gallstone
clinically used estrogens?
- estradiol (estrace)
- conjugated estrogen (premarin)
- ethinyl estradiol (estinyl)
- quinestrol (estrovis)
- estrone
- estradiol (estrace)
- conjugated estrogen (premarin)
- ethinyl estradiol (estinyl)
- quinestrol (estrovis)
- estrone
PK?
metabolize by CYP450.
combination c P-450 inducers can lead to failure of contraceptive effectiveness.
- estradiol (estrace)
- conjugated estrogen (premarin)
- ethinyl estradiol (estinyl)
- quinestrol (estrovis)
- estrone
Clinical uses?
- IM = long acting estrogen preparations are used in females c hypogandism.
- oral contraceptives in combo c progestins
- suppress FSH and LH secretion and inhibit ovulation. - postmenopausal hormone replacement therapy (HRT).
- HRT help and reduce hot flashes, prevent bone loss and fractures, decreased incidence of colon cancer, decreased urogenital atrophy, and increased feeling of well-being.
- estradiol (estrace)
- conjugated estrogen (premarin)
- ethinyl estradiol (estinyl)
- quinestrol (estrovis)
- estrone
Adverse effects?
- increased incidence of thromboembolism, changes in CHO & lipid metabolism, increased risk of elevated BP.
- increased incidence of breast & endometrial cancers
- migraine, cholestasis, and mood changes.
what is diethylstilbestrol (DES) and its a.e?
a nonsteroidal estrogen agonist
used in pregnancy result in female child to infertility and vaginal cancer.
- estradiol (estrace)
- conjugated estrogen (premarin)
- ethinyl estradiol (estinyl)
- quinestrol (estrovis)
- estrone
Contraindications?
- hx of thromboembolism
- breast & endometrial cancer
- pregnancy
- liver disease
Selective estrogen receptors modulators?
- tamoxifen
- raloxifene
- toremifene
tamoxifen
MOA?
antagonist effect on breast tissue but agonistic effect on liver, endometrium and bone.
tamoxifen
tx?
breast cancer
tamoxifen
A.E?
hot flushes (antagonist) and thrombosis (agonistic) risk of endometrial cancers.
toremifene
tx?
breast cancer and prevention of breast cancer in high-risk women
raloxifene
MOA?
antagonist at breast and but agonist at bone. no estrogenic effect on endometrium
no increased risk of endometrial cancer
raloxifene
Clinical applications?
- prophylaxis against breast cancers (in high risk pts)
2. prev of postmenopausal osteoporosis.
estrogen receptor antagonist?
fulvestrant
fulvestrant
Tx?
IM: breast cancer in tamoxifen resistant pts
fulvestrant
A.E?
hot flushes, infxn site rxns and HA.
Aromatase inhibitors?
- letrozole
- anastrozole
- exemestane
- letrozole
- anastrozole
- exemestane
MOA?
inhibit conversion of androgens to estrogen
- letrozole
- anastrozole
- exemestane
A.E?
hot flushes, decreased bone mineral density